Replies to post #11268 on Paradigm Medical Industries Inc. (PDMI)

[ENRIMOON]

RETIMAX adds technical and functional features at the traditional standard Electrophysiology of vision.

RETIMAX has been designed in order to perform innovative test for the early screening and follow–up of important pathologies like Glaucoma and ARM (age related Maculopaty), vascular retinal degeneration and other optic nerve diseases. In the surgery of cataract and posterior segment is an interesting predictive instrument for the monitoring of the visual function before and after surgery.
In the paediatric ophthalmology is useful for the testing of non-cooperative patients.

Thanks to the possibility to perform objective test independent of patient’s cooperation RETIMAX meet a wide interest inthe forensic medicine.Results obtained with RETIMAX areobjective early and standard. In the screening of Glaucoma the PERG allow the evaluation abnormality in the retinal Ganglion cells before modification of retina structure.
New software applications and analysis strategies allow the ophthalmologist to compare the results with normative data. Innovative electrodes give more comfort to the patient during the test.

RETIMAX is conform with ISCEV standard (International society for Clinical Electrophysiology of Vision) RETIMAX is up-gradable with Multifocal ERG, Multifocal PERG, Multifocal VEP.